The effects of moderate intensity walking on lipoprotein remodeling in postpartum Hispanic women are unknown. Methods: Sedentary postpartum Hispanic women (28.2 ± 5.6 y; BMI = 29.3 ± 3.3 kg/m 2 ) participating in a social support physical activity (PA) intervention, were randomly assigned to a 12-month walking program (walkers; n = 22; target 150 min/wk, moderate intensity) or a control group (nonwalkers; n = 22). Fasting lipids and cholesterol distribution within low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particles were measured at baseline (BL), 6 months, and 12 months. Results: Walkers had an 11% increase and nonwalkers a 7% decrease in HDL cholesterol from 6 to 12 months (P = .0367) without an effect on LDL cholesterol. Whereas nonwalkers had virtually no change in mean LDL particle size, walkers had a borderline reduction in LDL size from BL (268.7 ± 4.1 Å) to 6 months (266.9 ± 4.9 Å), followed by a significant increase in size by 12 months (269.7 ± 4.1 Å; P = .011). The proportion of cholesterol in large LDL particles decreased by 15% from BL to 6 months, but subsequently increased 25% by 12 months among walkers; changes among nonwalkers were smaller and in opposite direction (4% and -3%, respectively; P = .0004). Conclusions: Participation in the social-support PA intervention resulted in slightly increased HDL cholesterol concentrations and a modest and beneficial shift toward larger, less atherogenic LDL particles.
Among Hispanics, increased body weight has been associated with presence of the metabolic syndrome, hypertension, insulin resistance, diabetes, hyperlipidemias, and cardiovascular disease (CVD). [1] [2] [3] In particular, Mexican Americans have been reported to have greater prevalence of metabolic syndrome components than non-Hispanic whites and blacks. 4, 5 However, there is limited information regarding the presence of other atherogenic factors, such as smaller, denser low-density lipoprotein (LDL), in this population.
Excess weight gain during pregnancy and failure to lose weight postpartum have been associated with long-term obesity and the risk of developing dyslipidemia, diabetes, hypertension and CVD. 6 Postpartum Hispanic women are at particular risk due to higher prepregnancy obesity rates 7 and the presence of many contributors to excessive weight retention after childbirth (eg, role changes, cultural norms that promote sedentary behavior and overeating, living in obesogenic environments, postpartum depression, negative body image). 8 Specific information on how postpartum weight retention affects metabolic biomarkers among Hispanic women is scarce.
Late pregnancy is characterized by complex physiologic changes including alterations in lipid metabolism. These changes include an increase in circulating triglycerides 9, 10 and an accumulation of triglycerides in high-density lipoprotein (HDL) particles, 11 resulting in the formation of small, dense LDL and large buoyant HDL particles. 9, 10 Lipoprotein changes are partially reverted at 4 to 6 weeks postpartum, with further improvements after the lactation period. 9, 12 The role of physical activity (PA) in modulating lipoprotein changes in the postpartum period has not been thoroughly studied, and information related to changes in different lipoprotein subfractions with PA is lacking. The current study was conducted to examine cardiometabolic disease risk factors, particularly those associated with an unfavorable remodeling of the lipoprotein profile, in a subsample of women from the efficacy of Madres para la Salud (Mothers for Health; Madres) study, a theory-driven social support program to promote moderate-intensity PA, to reduce body fat in postpartum Hispanic women. It was hypothesized that enhancing social support from participation in Madres para la Salud would increase moderate-intensity PA and result in beneficial changes associated with a less atherogenic lipoprotein profile.
Methods

Participants
Study participants were enrolled in Madres para la Salud (Mothers for Health), a community-based social support intervention to promote PA in Hispanic postpartum women. 13 Participants were habitually sedentary Hispanic young women (18-40 years), 6 weeks to less than 6 months postpartum, and physically able to participate in moderate intensity walking recruited from the Phoenix metropolitan area. Exclusion criteria were a) participation in regular, strenuous PA (> 150 minutes/week of moderate PA); b) JPAH Vol. 12, No. 9, 2015 severe musculoskeletal or cardiorespiratory problems that would preclude PA; c) pregnancy or planning to become pregnant within 12 months; d) current use of antidepressants, anticoagulants, oral steroids, nonsteroidal anti-inflammatory drugs, or hypolipidemic medications; e) infectious illness, chronic systemic inflammatory diseases (eg, rheumatoid arthritis), or other acute illness that may affect systemic inflammation at baseline; f) BMI less than 25 or greater than 35 kg/m 2 ; and h) presence of osteoporosis at baseline (bone mineral density > 2.5 SD below the average).
Study Design
Madres para la Salud (Mothers for Health) was a 12-month randomized controlled social support PA intervention for sedentary Hispanic postpartum women designed to increase moderate intensity walking. Detailed study design and intervention outcomes have been reported elsewhere. [13] [14] [15] The study was approved by Arizona State University's Institutional Review Board and the Maricopa Integrated Health System Human Subjects Review Board. All participants provided written consent to participate.
Following informed consent, participants were randomly assigned to a 12-month social support PA intervention (walkers) or an attention-control group (nonwalkers) using a SAS Proc Plan to generate the randomization schedule. Because recruitment and the intervention were done in waves or cohorts, participants were randomized in blocks using a seed to generate a randomization list for each wave or cohort with equal numbers for the intervention and the control group. Because of cost, a subsample of 44 women randomly selected by using a random number generator, were invited to complete additional data collection procedures for the assessment of cardiometabolic disease risk factors (see below) and were included in the current analysis. Data were collected at baseline, 6 and 12 months post randomization. These included measures of cardiometabolic disease risk factors (anthropometric measurements, blood pressure, and biomarkers of lipoprotein and glucose metabolism), dietary intake, and physical activity. Of the 44 women selected for this analysis, 33 and 31 participants completed 6-month and 12-month data collection procedures, respectively.
Participants assigned to the PA intervention (walkers) were allocated to Promotora (community health worker)-led walking groups that met at select community-based locations convenient to group members' area of residence. The first 3 months of the intervention consisted of 12 weekly support sessions immediately followed by walking sessions through which Promotoras provided training to ensure proper stretching and cooling down procedures, and to ensure participants sustained a walking pace of moderate intensity; women in the intervention group completed walking records of the days and times of PA. After the 12 support sessions concluded, the Promotoras held weekly 30-minute walking sessions with group members for the remainder of the study, after which they assessed adherence to the walking dose, and checked participants' walking records. Participants in the control group received weekly newsletters with information unrelated to PA, such as breast-feeding, sun protection, and scripted follow-up phone calls throughout the duration of the study. Neither of the study groups received information about diet or dietary change.
The prescribed walking dose was consistent with the 2008 Physical Activity Guidelines for Adults, which recommend that adults engage in at least 150 minutes/week of moderate-intensity PA. 16 Participants in the PA intervention group were instructed to complete a minimum of 30 minutes/day of brisk walking for at least 5 days of the week, with the option of completing the prescribed dose by accumulating bouts of at least 10 minutes each.
Measures
At each data collection time point, participants arrived to the study site after a 12-hour overnight fast. Upon arrival, height and weight, and waist circumference were measured in triplicate following standard procedures. 13 Body composition (percent body fat) was measured using a portable 4-terminal bioelectric impedance (BIA) system (Tanita Corporation of America, Inc., Arlington Heights, IL). After a 5-minute rest, blood pressure (BP) was measured 3 times on the left arm using an Omron IntelliSense HEM-907XL automated blood pressure monitor (Omron Healthcare, Inc., Bannockburn, IL). Fasting blood was collected from the antecubital vein into EDTA-or EDTA/sodium fluoride-containing evacuated tubes for the measurement of biomarkers and glucose, respectively. Plasma was separated by centrifugation at 1100 × g at 4°C for 20 minutes and stored at -80°C until analysis.
Biomarkers of Cardiometabolic Disease Risk
Plasma glucose and lipids (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides) were measured using an automated chemistry analyzer (Cobas C111; Roche Diagnostics, Indianapolis, IN). Plasma insulin was measured using Human Insulin Specific RIA kit (Millipore, Billerica, MA).
The cholesterol distribution in LDL and HDL subfractions and mean LDL particle diameter were determined by the Lipoprint/ Lipoware system (Quantimetrix Co., Redondo Beach, CA). 17 The relative percentage of cholesterol in large and small LDL particles was calculated by adding the proportion of cholesterol in fractions LDL 1 plus LDL 2 , and LDL 3 through LDL 7 , respectively. The relative percentage of cholesterol in large, intermediate, and small HDL particles was calculated by adding the proportion of HDL cholesterol in fractions HDL 1 through HDL 3 , HDL 4 through HDL 6 , and HDL 7 through HDL 10 , respectively.
The number of metabolic syndrome components was assessed using ATP III criteria 18 based on the presence of any of the following components: 1) abdominal obesity defined as waist circumference ≥ 102 cm in men and ≥ 88 cm in women, 2) plasma triglycerides ≥ 150 mg/dL, 3) HDL-cholesterol ≤ 40 mg/dL in men and ≤ 50 mg/ dL in women, 4) hypertension defined as blood pressure ≥ 130/85 mm Hg, and 5) fasting plasma glucose ≥ 100mg/dL.
Physical Activity Assessment
Participants completed the Stanford Brief Activity Survey (SBAS), 19 and were asked to wear an Omron HJ-720ITC pedometer (Omron Healthcare, Inc., Bannockburn, IL) for 7 consecutive days immediately after each data collection point. Pedometer-generated data included total steps/day and moderate-intensity (aerobic) walking in min/day, corresponding to the amount of time spent walking at a cadence associated with moderate-intensity exercise (> 100 steps/min).
Diet Assessment
Dietary intake data were obtained by trained bilingual staff using 3 unannounced 24-hour recalls that included a weekend day at each time point, following the 5-step multiple pass method. 20 Dietary data were analyzed using the Nutrition Data System for Research ( 
Statistical Analysis
Statistical analyses were carried out using the Statistical Program for the Social Sciences (SPSS) 17.0 for Windows (SPSS, Inc., Evanston, IL), SAS version 9.3 (SAS Institute, Cary, NC), and R version 3.1.0 (R Core Team). Before the analyses, descriptive statistics and graphs were used to summarize variable distributions. Data are presented in text and tables as mean ± standard deviation (SD). The general approach we used for modeling changes in waist circumference, metabolic markers, blood lipids, diet composition, and PA followed a 2 × 3 Group (Intervention vs. Control) × Time (repeated measures taken at baseline, 6 months, and 12 months) analysis of variance (ANOVA) framework. Tests of overall main effects and the Group × Time interaction were followed by planned contrasts among cell means, testing 1) Group differences at each time point and 2) Group differences in the degree of change a) from baseline to 6 months, b) from 6 months to 12 months, and c) from baseline to 12 months. Statistical significance was considered at α < 0.05.
Results
Baseline Participant Characteristics
Most participants were either married (46%) or living as married (43%; Table 1 ). Most participants had completed at least high school education (64%); 36% of participants had only completed elementary or middle school. Yearly household income was below $20,000 for 73% of participants, and most participants were unemployed (66%) or had never been employed (16%). Mean time in the U.S. was 12.0 ± 8.0 years; 38 participants (86%) were foreign-born.
Mean age of study participants was 28.2 ± 5.6 years ( Table 2 ). The mean BMI of 29.3 ± 3.3 kg/m 2 was in the overweight range, and participants had a mean 38.2 ± 4.7% of body fat. Mean values for BP, fasting plasma glucose, and fasting triglycerides were within desirable values. Systolic and diastolic BPs were significantly higher in the intervention group than in the control group (P-values = 0.002 and 0.005, respectively). Participants had elevated waist circumference (99.8 ± 9.0 cm) and low HDL-cholesterol concentrations (43 ± 9 mg/dL). Per National Cholesterol Education Program Adult Treatment Panel (NCEP ATP) III criteria, 21 participants had optimal and near-optimal concentrations of total-and LDL-cholesterol at 164 ± 37 mg/dL, and 106 ± 33 mg/dL, respectively, with levels on both total-and LDL-cholesterol being higher in the intervention group than in the control group (P-values = 0.049 and 0.045, respectively).
On average, participants were 12.1 ± 7.1 weeks postpartum and had 2.8 ± 1.2 births. There was no significant difference in weeks postpartum at baseline between intervention (12.9 ± 7.2 weeks) and control groups (11.4 ± 7.0 weeks). There were no group differences in baseline feeding methods based on responses to a 5-category measure (breastfeeding only, breastfeeding more than bottle feeding, breastfeeding and bottle feeding about equally, bottle feeding more than breastfeeding, bottle feeding only; n = 43, P = .69).
Physical Activity and Dietary Intake
Physical activity was generally low among all participants throughout the duration of the study. At baseline, participants performed 4.5 ± 7.1 min/day of aerobic walking time and 5575 ± 2373 steps/day ( Table 2) . As assessed by the SBAS, the level of PA was classified as inactive, light, and moderate for 52.3%, 31.8%, and 15.9% of participants, respectively.
As objectively assessed by use of pedometers, there was a significant increase in total step counts over time for both groups (P time < 0.001; Table 3 ). From baseline to 6 months there was an increase in mean step counts of 2171 steps/day (38%) among walkers and 1845 steps/day (34%) among nonwalkers. This was followed by a decrease in mean step counts from 6 to 12 months of 1238 steps/day (16%) among walkers and 1446 steps/day (25%) for nonwalkers. Thus, the net increase in step counts from baseline to 12 months was small. Changes in aerobic walking significantly differed over time between groups (P time×group = 0.001); walkers achieved more aerobic steps than nonwalkers at 6 and 12 months (P-values < 0.01). Subjective assessment of PA indicated significantly different changes in SBAS score over time between groups (P time×group = 0.003). SBAS score was significantly higher for walkers than nonwalkers at 6 and 12 months (P-values < 0.01).
There were no significant group differences or group x time interactions on total energy intake per day, or the percentages of energy from fats, total carbohydrates, sugars, and protein, and grams of fiber consumed (Table 3 ). There was a main effect of time on percent of energy from protein (an increase from baseline to 6 months, followed by a decrease, P = .045) and on fiber consumption (monotonic decrease from baseline to 12 months, P = .006).
Cardiometabolic Disease Risk Factors
There were no significant differences in weight, waist circumference, or body fat percentage over time between walkers and nonwalkers (Table 4) . Change in systolic BP over time differed significantly between groups (P time×group = 0.002); walkers had higher systolic BP than nonwalkers at baseline and 6 months postrandomization (P-values < 0.05). Linear change (decrease) in systolic BP from baseline to 12 months postrandomization was significantly different between groups (6% reduction for walkers and 1% increase for nonwalkers; P < .01), and while systolic BP in walkers showed a modest decrease from 6 months to 12 months, it increased in nonwalkers over the same time. Walkers had higher diastolic BP than nonwalkers at baseline and 6 months postrandomization, but change in diastolic BP over time did not differ significantly between groups. Mean fasting glucose concentrations remained within normal ranges throughout the study and did not significantly differ in concentration or change over time between groups (Table 4 ). There were no significant between-group differences in levels or change in insulin. However, insulin concentrations were consistently elevated throughout the study for both groups.
There were no significant changes in total-or LDL-cholesterol concentrations throughout the intervention (Table 4) . Participants in the walking group had significantly more total and LDL-cholesterol concentrations at all 3 time points (P group < 0.01), however all values were within near optimal concentrations. Although HDL-cholesterol concentrations remained below desirable concentrations (<50 mg/ dL for women) 21 for both groups throughout the study, walkers had an 11% increase and nonwalkers a 7% decrease in HDL cholesterol from 6 to 12 months (P < .05). Walkers had significantly higher triglycerides than nonwalkers (P group = 0.019), although all participants had normal triglycerides concentrations.
Distribution of Cholesterol in LDL and HDL Subfractions
There were no intervention effects on LDL-cholesterol concentrations (see Table 4 ), but change in LDL particle size and the proportion of cholesterol in large LDL particles over time did differ between groups (P time×group = 0.011 and 0.028, respectively; Table  5 ). Whereas nonwalkers had virtually no change in mean LDL particle diameter, walkers had a borderline significant reduction in LDL diameter from BL (268.7 ± 4.1 Å) to 6 months (266.9 ± 4.9 * P < 0.05, **P < .01 for comparisons of means for walkers vs. nonwalkers by time point. † P < .05 for comparisons of change from baseline to 6 months for walkers vs. nonwalkers. ‡ P < .05, ‡ ‡ P < .01 for comparisons of change from baseline to 12 months for walkers vs. nonwalkers. § P < .05, § § P < .01 for comparisons of change from 6 months to 12 months for walkers vs. nonwalkers.
Å; P = .065), followed by a significant increase in diameter by 12 months (269.7 ± 4.1 Å; P = .005). The proportion of cholesterol in the largest LDL particles decreased by 15% from BL to 6 months, but subsequently increased 25% by 12 months among walkers; changes among nonwalkers were smaller and in opposite direction (4% and -3%, respectively; P < .001). As a result, the proportion of cholesterol in large LDL particles among walkers was 11% greater at baseline (P = .019) and 10% greater at 12 months (P = .048) relative to that of nonwalkers. There were no significant differences in the proportion of cholesterol in small LDL particles. There was a significant time effect on the proportion of cholesterol in different HDL subfractions for all participants, but this effect did not differ between groups. Relative to baseline, the proportion of HDL cholesterol in large HDL particles was 11% higher at 12 months postrandomization (P time = 0.005). In contrast, the proportion of HDL cholesterol in intermediate HDL particles was 4% and 6% lower at 6 months and 12 months, respectively (P time = 0.012).
Discussion
Madres para la Salud was a randomized controlled trial designed to reduce postpartum body weight among Latinas using a social support mediated walking intervention. Despite the weight status of participants who were overweight/obese, the subsample in this analysis was comprised of young postpartum women with relatively few metabolic abnormalities that primarily included elevated waist circumference and low HDL-cholesterol concentrations. Although for the most part the cardiometabolic risk factors assessed, including weight, remained unchanged, walkers experienced favorable, albeit small, changes in BP, distribution of cholesterol in large LDL particles and LDL particle size, and HDL cholesterol.
The intervention resulted in increased PA, as indicated by greater aerobic walking time and SBAS score among walkers. Nevertheless, PA among study participants was low throughout the study; based on step counts, women were classified as low active (5000-7499 steps/day) at baseline, and walkers only reached the "somewhat active" category (7500-9999 steps/day) at the 6-month time point. In general, postpartum women have been documented to spend most of their time in sedentary activities. 14, 22, 23 The increase in PA observed over time in both groups could be in part attributed to intervention effects as well as recruitment attention to health mailed messages to the control groups.
Overall, PA increased slightly in the control group and showed limited sustainability in the intervention group. The possible reasons for limited treatment effects may be related to the notion that new mothers were adjusting to the challenges of caring for an infant, multiple other small children in the home, and only gradually being able to incorporate more activities to their daily life. Although the possibility that women in both groups walked more when they were wearing the pedometer cannot be ruled out, the differential increase in aerobic walking between groups suggests a small effect of the intervention. Nevertheless, the increase in aerobic walking was small (about 12 min/day); among walkers PA declined once Promotoras were no longer holding support sessions. * P < 0.05, ** P < .01 for comparisons of means for walkers vs. nonwalkers by time point. † P < .05 for comparisons of change from baseline to 6 months for walkers vs. nonwalkers. ‡ P < .05, ‡ ‡ P < .01 for comparisons of change from baseline to 12 months for walkers vs. nonwalkers. § P < .05, § § P < .01 for comparisons of change from 6 months to 12 months for walkers vs. nonwalkers. Abbreviations: LDL, low-density lipoprotein; HDL, high-density lipoprotein.
* P < 0.05, ** P < .01 for comparisons of means for walkers vs. nonwalkers by time point. † P < .05, for comparisons of change from baseline to 6 months for walkers vs. nonwalkers. ‡ P < .05, ‡ ‡ P < .01 for comparisons of change from baseline to 12 months for walkers vs. nonwalkers. § P < .05, § § P < .01 for comparisons of change from 6 months to 12 months for walkers vs. nonwalkers.
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Physical Activity and Lipids
Existing evidence suggests that aerobic exercise results in small LDL-cholesterol reductions (about 3%) especially when combined with weight loss. [24] [25] [26] Although exercise training has been reported to raise HDL-cholesterol concentrations (by about 2% to 5%), evidence is inconsistent; effects, when present, seem to be greater with greater triglycerides or lower HDL concentrations at baseline. 24, 25 Previous PA interventions resulting in lipid changes 27, 28 have mainly consisted of supervised training sessions in which the dose of PA (frequency, intensity, and/or duration) was greater than that achieved by participants of the current study. In contrast to supervised structured PA interventions in controlled environments, behavioral interventions conducted in freeliving conditions have had less consistent effects on lipoproteins. Among adults with type 2 diabetes, a pedometer-based intervention delivered in 1 face-to-face session followed by 7 phone calls over 24 weeks resulted in no significant differences in lipids, glucose or body weight despite a significant increase in about 2700 steps/ day among participants in the intervention group (vs. a reduction of about 1250 steps/day among those in the control group). 29 In Pasos Adelante, a 12-week chronic disease prevention program in which community health workers led walking groups among Hispanic adults (92% women), no significant prepost changes in LDL-or HDL-cholesterol, triglyceride, and glucose concentrations were observed despite increased self-reported PA relative to baseline. 30 It is possible that, similar to the current study, the magnitude of PA changes attained by participants was of smaller magnitude than what would cause physiologically meaningful changes in lipid concentrations. Interestingly, a meta-analysis of PA interventions targeting minority adults documented that neither supervised exercise interventions nor behavioral interventions resulted in significant changes in lipid concentrations despite small effects on anthropometric measurements, potentially due to small effects on PA. 31 In the current study, favorable changes in triglycerides, HDL cholesterol, and LDL particle size were achieved from 6 to 12 months, and suggest benefits from longer-term interventions.
Although lipid concentrations are susceptible to alterations due to dietary changes, participants in the current study did not change their intake of nutrients likely to affect lipoprotein metabolism (eg, energy, fat, carbohydrates, sugars, fiber). Moreover, observed differences in diet over time occurred in both walkers and nonwalkers.
Physical Activity and Lipoprotein Subfractions
Lipoproteins are heterogeneous particles regarding their size, density and composition, with size being inversely correlated to cholesterol content and atherogenicity. 32, 33 The presence of small, dense LDL particles has been associated with type 2 diabetes, metabolic syndrome, and coronary artery disease. 34, 35 Larger HDL particles are regarded as cardioprotective, and their presence has been associated with lower cardiovascular disease risk. 32, 36 In contrast, small HDL particles have been reported as a trait of abdominal obesity-related dyslipidemias. 37 In the current study the proportion of cholesterol in large LDL particles among walkers was greater at baseline and at 12 months postrandomization relative to that of nonwalkers. In cross-sectional studies regular PA, particularly aerobic activity, has been associated with the presence of larger LDL and HDL particles. 38, 39 In randomized controlled interventions, PA has been reported to favorably modify LDL particle size even in the absence of LDL cholesterol concentration changes. 40 Results from a 6-month randomized trial with overweight and obese adults with mild dyslipidemia demonstrated that even low amounts of PA (equivalent to walking 12 miles per week) resulted in LDL particle size increase regardless of intensity (moderate, 40% to 55% VO 2 max vs. high, 65% to 80% VO 2 max). 40 However, high amounts of PA (equivalent of 20 miles per week) were necessary to observe a reduction in cholesterol in small LDL particles, and an increase in HDL-cholesterol, cholesterol in large HDL particles, and HDL particle size. 40 
Lipids and Lipoproteins in the Postpartum Period
There is limited information regarding the role of PA in modulating lipoprotein changes and lipoprotein subfractions in the postpartum period. Despite an improvement in cardiovascular fitness, a 12-week aerobic exercise intervention (45 min/day, 5 days/week) among women 6 to 8 weeks postpartum resulted in only marginally significant increases in HDL cholesterol, with no changes in other lipid concentrations. 41 Conversely, in a 16-week weight loss intervention starting at 7 to 8 weeks postpartum that included supervised walking sessions 3 to 4 times/week, low-and moderate-intensity PA induced significant reductions in fasting glucose (-5%) and LDL cholesterol (-9%) concentrations relative to sedentary controls. 42 In contrast to previous reports, women in the current study were recruited later in the postpartum period (mean 12 weeks) and more likely to be at a stage at which pregnancy-related lipid changes would have already reverted. 9, 12 In animal studies early lactation was associated with lower triglycerides and VLDL particles, and more abundant larger LDL particles; once lipoprotein lipase from mammary gland is downregulated because of lactation cessation, triglyceride-rich particles became more abundant and LDL particles increased in size. 43 Although breastfeeding duration data were not collected, only a small percentage of participants were exclusively breastfeeding at baseline and would have been susceptible to major lipoprotein fluctuations because of breastfeeding cessation. Moreover, there were no differences between groups in child feeding method at baseline.
The current study has several limitations worth discussing. Overall, nonwalkers had a more favorable metabolic profile than walkers as indicated by lower BP, total-, LDL-cholesterol, and triglyceride concentrations. Although the subsample of participants for this analysis was randomly selected, the small sample size may have limited the ability to select weighted subgroups or to provide adequate statistical power to detect differences. Nevertheless, the differences between walkers and nonwalkers were maintained throughout the study and did not seem to result in unexpected differential responses between groups. The intervention was targeted toward overweight/obese postpartum women, regardless of their metabolic health. It is possible that greater effects could have been observed among individuals with a metabolic profile indicative of greater risk at baseline. Because the study was not conducted in a controlled environment, the walking dose attained by participants in the intervention group was low, and potentially insufficient to elicit changes in lipids and other cardiovascular risk factors. It is also possible that factors others than those accounted for in the current study (eg, breastfeeding duration, hormonal changes) could have affected results.
The study also has several strengths worth highlighting. Because of its community-based nature, this study is more likely to reflect PA behavior changes that could be attained in real-life circumstances. Aside from providing social support, Promotoras provided supervised walking, which was instrumental in ensuring that participants walked at an intensity that would increase aerobic PA, as well as providing an additional source for social support.
Moreover, in addition to the use of subjective measures (SBAS), PA was assessed using objective measures (pedometers), which allowed for identifying attainment of health-enhancing aerobic walking. Finally, the current study was carefully designed to incorporate elements of cultural sensitivity and ensure intervention fidelity. 13, 44 In conclusion, participation in the social-support PA intervention resulted in slightly increased HDL cholesterol concentrations, a modest and beneficial shift toward larger, less atherogenic LDL particles, and small reductions in systolic BP. Whether a higher amount and intensity of exercise than those attained in the current and previous studies can provide additional benefits in lipoprotein profile among postpartum women needs to be further investigated. Future research is also needed to better understand how naturally occurring postpartum-and lactation-related fluctuations in lipoprotein metabolism are modulated by PA.
